UNASSIGNED: 52 Background: @entity34 ( @entity34 ), a critical component of survivorship care plans, were identified as a tool to improve long-term outcomes for the 12 million @entity5 survivors alive in the United States. METHODS: In 2010, the Lance Armstrong Foundation fielded the LIVESTRONG Survey for @entity1 Affected by @entity5 . Respondents were recruited through several channels including partnerships with national organizations such as ASCO. Over a 9-month period, 12,682 @entity1 completed the survey, including 3,682 post-treatment @entity5 survivors (PTCS). The survey addressed post-treatment concerns including receipt of @entity34 . Full survey results were presented at the 2011 ASCO Annual Meeting. RESULTS: Receipt of @entity34 data was available for 3,042 PTCS: average age (50); female (65%); average time since diagnosis (6 years); received a @entity34 (34%). PTCS who received @entity34 reported that they were closer to time since diagnosis or since treatment ended (p < 0.01); more likely to have received chemotherapy (p < 0.01); more often receiving the majority of their health care from a medical oncologist (p < 0.05); experiencing significantly fewer (p < 0.05) post-treatment emotional concerns (including emotional distress; fears of recurrence; concerns about family risk; and appearance concerns) and were more likely to have received care; significantly less likely to say that they had "learned to live with" their concerns (p <0.05)-the most common reason among @entity1 for not receiving care. Finally, receipt of a @entity34 was related to higher information efficacy (p < 0.01; which appeared to mediate the relationship between receipt of a @entity34 and fewer emotional concerns). PTCS who received a @entity34 more often reported that their needs were met including information received about possible late-effects; care they got during treatment; and care they received after treatment. CONCLUSIONS: These results support the provision of @entity34 to PTCS. Receipt of @entity34 was associated with a variety of positive outcomes; however, only about one-third of PTCS received one. Future studies focused on @entity1 perspectives on care planning tools, such as treatment summaries and care plans, can help to improve optimal survivorship care delivery.

Associations between receipt of a treatment summary, emotional concerns, and patterns of care among post-treatment XXXX survivors.

@entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'Cancer'] @entity1 :: ('9606', 'Species') :: ['participants', 'patient', 'people', 'People'] @entity34 :: ('MESH:D016609', 'Disease') :: ['Treatment summaries', 'TS']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
